Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Stock Short Interest Jumps 3,213.1%

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) was the recipient of a significant growth in short interest during the month of October. As of October 30th, there was short interest totaling 124,174 shares, a growth of 3,213.1% from the October 15th total of 3,748 shares. Based on an average daily volume of 1,427,500 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are short sold.

Advanced Medical Isotope Price Performance

RDGL stock opened at $0.04 on Wednesday. Advanced Medical Isotope has a 1-year low of $0.04 and a 1-year high of $0.12. The firm has a fifty day moving average price of $0.05 and a two-hundred day moving average price of $0.06. The firm has a market cap of $22.65 million, a price-to-earnings ratio of -4.47 and a beta of -0.45.

About Advanced Medical Isotope

Advanced Medical Isotope Corp. (OTCMKTS:RDGL) is a medical technology company developing isotope-based treatments for cancer and other localized medical conditions. Its work centers on targeted radiation therapies designed to deliver radioactive material directly to tumors while limiting exposure to surrounding healthy tissue. The company’s principal product platform is Radiogel, an injectable, biodegradable gel intended to deliver therapeutic radioisotopes locally within solid tumors. Advanced Medical Isotope has also developed IsoPet, a related isotope-based treatment for certain cancers in companion animals.